Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone in Bipolar Disorder With Anxiety
NCT00277654Phase 3Completed
- Sponsor
- Lindner Center of HOPE
- Start
- Feb 2004
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risperidone in bipolar disorder (BD), anxiety disorder, sponsored by Lindner Center of HOPE. Started Feb 2004; status: completed.
02
Drugs
risperidone
03
Conditions
bipolar disorder (BD)anxiety disorder
Beyond the preview
Go deeper on NCT00277654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277654.